Quantification of Extracorporeal Fibrin Deposits in Haemodialysis with Minimal and Conventional Heparinization

The effects of minimal intermittent heparinization and of conventional heparinization on endogen fibrinogen concentration as well as on fibrin depositis were studied on 17 on patients hemodialysis. It was shown that the minimal intermittent heparinization did non reduce dialysis efficiency and that a total heparin dosage of 6,000 units is the lowest safe limit.

[1]  J. Porush,et al.  Low-dose heparin in routine hemodialysis monitored by activated partial thromboplastin time. , 1979, Artificial organs.

[2]  U. Binswanger,et al.  Minimal intermittent heparinization during hemodialysis. , 1979, Nephron.

[3]  G. Vogel,et al.  [Heparin dosage in chronic hemodialysis (author's transl)]. , 1977, Medizinische Klinik.

[4]  H. Kuhlmann.  [Therapy of diabetic glomerulosclerosis (Kimmelstiel-Wilson syndrome)]. , 1976, Deutsche medizinische Wochenschrift.

[5]  S. Wessler.  Heparin as an antithrombotic agent. Low-dose prophylaxis. , 1976, JAMA.

[6]  E. Cooke,et al.  Letter: Monitoring during low-dose heparin prophylaxis. , 1976, The New England journal of medicine.

[7]  M. Lie,et al.  Heparin assay in plasma: a comparison of five clotting methods. , 1975, Thrombosis research.

[8]  B. Bull,et al.  Evaluation of tests used to monitor heparin therapy during extracorporeal circulation. , 1975, Anesthesiology.

[9]  J. A. Hickman,et al.  Behaviour of commercially prepared I-125 fibrinogen in metabolic studies. , 1975, Journal of clinical pathology.

[10]  Godal Hc.  Heparin assay methods for control of in vivo heparin effects. , 1975 .

[11]  Lasch Hg,et al.  Heparin therapy of diffuse intravascular coagulation (DIC). , 1975 .

[12]  E. Lüscher,et al.  Platelet Heparin-Neutralizing Factor (Platelet Factor 4) , 1975, Thrombosis and Haemostasis.

[13]  J. Kiss.  Chemistry of Heparin , 1975, Thrombosis and Haemostasis.

[14]  V. Kakkar.  Low Dose Heparin in the Prevention of Venons Thromboembolism , 1975, Thrombosis and Haemostasis.

[15]  M. B. Zucker,et al.  Effect of Heparin on Platelet Function , 1975, Thrombosis and Haemostasis.

[16]  Jacques Lb.  Letter: Standardisation of heparin for clinical use. , 1975 .

[17]  R. Rosenberg.  Actions and interactions of antithrombin and heparin. , 1975, The New England journal of medicine.

[18]  H. Godal.  Heparin Assay Methods for Control of in Vivo Heparin Effects , 1975, Thrombosis and Haemostasis.

[19]  H. Lasch,et al.  Heparin Therapy of Diffuse Intravascular Coagulation (DIC) , 1975, Thrombosis and Haemostasis.

[20]  Y. Nosé.  Die künstliche Niere: Ein Leitfaden für Ärzte, Krankenpflegepersonal und Patienten , 1974 .

[21]  S. Wessler,et al.  On the Antithrombotic Action of Heparin , 1974, Thrombosis and Haemostasis.

[22]  H. Champion,et al.  INDICATIONS FOR EARLY HÆMODIALYSIS IN MULTIPLE TRAUMA , 1974 .

[23]  C. Mielke,et al.  A simple method of heparin management during prolonged extracorporeal circulation. , 1974, The Annals of thoracic surgery.

[24]  V. Heinze,et al.  [Changes of plasma coagulatiion and blood platelet function in patients with kidney insufficiency and their modification through homodialysis, kidney transplantation and acetylsalicylic acid]. , 1974, Die Medizinische Welt.

[25]  T. Cocke,et al.  Regional vs "tight" heparinization in hemodialysis. , 1974, Proceedings of the Clinical Dialysis and Transplant Forum.

[26]  H. Champion,et al.  Indications for early haemodialysis in multiple trauma. , 1974, Lancet.

[27]  J. Wallin,et al.  Monitoring heparin therapy in hemodialysis. A report on the activated whole blood coagulation time tests. , 1973, JAMA.

[28]  S. Epstein,et al.  Statistical correlation and heparin sensitivity of activated partial thromboplastin time, whole blood coagulation time, and an automated coagulation time. , 1973, American journal of clinical pathology.

[29]  E. Hiller.  Überwachung der Heparintherapie bei thromboembolischen Erkrankungen , 1973 .

[30]  S. Wessler,et al.  Plasma heparin: a unique, practical, submicrogram-sensitive assay. , 1973, The Journal of laboratory and clinical medicine.

[31]  S. Stock.  STANDARDISATION OF HEPARIN FOR CLINICAL USE , 1972 .

[32]  R. Piessens,et al.  Metabolism and Distribution of Fibrinogen. I. FIBRINOGEN TURNOVER IN PHYSIOLOGICAL CONDITIONS IN HUMANS , 1972, British journal of haematology.

[33]  K. Seiler,et al.  Kontrolle der regionalen Heparinisierung der Hämodialyse mit einer vereinfachten Thrombinzeitbestimmung , 1972 .

[34]  V. Kakkar.  The diagnosis of deep vein thrombosis using the 125 I fibrinogen test. , 1972, Archives of surgery.

[35]  W. Saggau,et al.  [Changes of blood coagulation in patients with chronic kidney diseases and hemodialysis]. , 1972, Die Medizinische Welt.

[36]  Ray Pk,et al.  Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy. , 1971 .

[37]  T. A. Harper,et al.  Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy. , 1971, The Journal of laboratory and clinical medicine.

[38]  H. Köstering,et al.  [Anticoagulant treatment for avoiding the shunt-induced thrombosis in patients on hemodialysis]. , 1970, Medizinische Klinik.

[39]  S. Wessler,et al.  Heparin-accelerated inhibition of activated factor X by its natural plasma inhibitor. , 1970, Biochimica et biophysica acta.

[40]  S. Zucker,et al.  Control of heparin therapy. Sensitivity of the activated partial thromboplastin time for monitoring the antithrombotic effects of heparin. , 1969, The Journal of laboratory and clinical medicine.

[41]  S. Wessler,et al.  Investigation of the Apparent Thrombogenicity of Thrombin , 1968, Thrombosis and Haemostasis.

[42]  C. R. Frisch,et al.  Relationship of the partial thromboplastin time to the Lee-White coagulation time. , 1968, Technical bulletin of the Registry of Medical Technologists. American Society of Clinical Pathologists. Registry of Medical Technologists.

[43]  M. Corn,et al.  Control of Heparin Therapy With Activated Partial Thromboplastin Times , 1967 .

[44]  S. Frye,et al.  Use of the activated partial thromboplastin time in the control of heparin administration. , 1966, Clinical chemistry.

[45]  H. Brögli.  Der Mechanismus des sogenannten »Heparin-Rebound« nach extrakorporellem Kreislauf , 1965, Thrombosis and Haemostasis.

[46]  D. Bittner,et al.  The partial thromboplastin time (cephalin time) in anticoagulation therapy. , 1962, American journal of clinical pathology.

[47]  L. Christensen.  The turnover of plasma fibrinogen. , 2009, Acta medica Scandinavica.

[48]  J. Graham,et al.  Diagnosis and control of the hemophilioid states with the partial thromboplastin time (PTT) test. , 1958, American journal of clinical pathology.

[49]  V. Richards,et al.  Studies in regional heparinization. I. The use of simultaneous neutralization with protamine; preliminary studies. , 1956, The New England journal of medicine.

[50]  P. White,et al.  A CLINICAL STUDY OF THE COAGULATION TIME OF BLOOD , 1913 .